Lifordi Immunotherapeutics, Inc.
PrivateLast Round
Series A
Extension
Nov 18, 2025
Total Funding Raised
$112M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lifordi Immunotherapeutics, Inc. is a biotechnology company that develops targeted antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lifordi Immunotherapeutics, Inc. Comparables
Compare Lifordi Immunotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 79% | |
| AbbVie | 76% | |
| AbolerIS Pharma | 71% | |
Lifordi Immunotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 18, 2025 |
Key People
Founding team and executive leadership
Lifordi Immunotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series A, Series A Extension |
| 5AM Ventures | Series A, Series A Extension |
| Sanofi Ventures | Series A Extension |
| Atlas Venture | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 59% MoM, reaching 12.4K.
- Jan 24, 2026
Monthly visitors increased 1486% MoM, reaching 7.8K.
Lifordi Immunotherapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lifordi Immunotherapeutics, Inc.'s valuation, stock price, and market status.